Quantcast

Latest Melanoma Stories

2014-06-16 23:07:52

Tanning and sun exposure increases risk, but early detection is almost 100% effective. (PRWEB) June 16, 2014 We all enjoy having fun in the great outdoors. Whether someone is hiking, swimming horseback riding, or just having a picnic, the lure of a sunny day is hard to resist. Doctors have been telling people for years to wear sunscreen when they go outdoors, but the honest truth is that few people listen. The reason for this concern is of the lurking danger of melanoma, which is the most...

2014-06-16 08:28:29

Company continues to engage leading cancer treatment centers to investigate non-invasive methods of cancer mutation detection in order to advance patient care SAN DIEGO, June 16, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time...

2014-06-10 12:30:10

MADISON, N.J., June 10, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based on the FDA-approved THxID(®)-BRAF test from bioMerieux, a world leader in the field of in vitro diagnostics. The THxID(®)-BRAF test is a companion diagnostic for two treatments for melanoma. The test is intended to be used as an aid in selecting patients with melanoma whose tumors carry the BRAF...

2014-06-04 23:13:56

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) June 04, 2014 The prescription drug safety advocates at DrugNews.net are alerting patients who have taken popular erectile dysfunction drugs like Viagra of new information on the site. A recent study found that men taking these medications were nearly twice as likely to develop melanoma skin cancer*. DrugNews is a...

2014-06-03 16:24:29

Michael Gabriel, a leading Brooklyn pediatrician reveals how to properly apply sunscreen for it to be effective. BOHEMIA, N.Y., June 3, 2014 /PRNewswire-iReach/ -- Dr. Michael Gabriel of GPM Pediatrics, a Brooklyn pediatrics center, responds to an article that says new guidelines have been set in the application of sunscreen for it to be effective. (Photo: http://photos.prnewswire.com/prnh/20140603/93567) According to the article published by eMissourian.com on May 23(rd), "The...

2014-06-03 08:31:55

OTTAWA, June 3, 2014 /CNW/ - The Canadian Dermatology Association (CDA) is challenging young people across Canada to put their creativity to work and make a short video about sun safety as part of National Sun Awareness Week, June 2(nd) - 8(th). This is the third year the CDA is hosting the Sun. Camera. Action. video contest and hopes to see many more great videos. "Getting young people involved in awareness efforts for sun safety is essential," says Dr. Cheryl Rosen, National...

2014-06-02 12:29:47

Six Phase 3 / Pivotal Trials with Array's MEK Inhibitors Advancing BOULDER, Colo., June 2, 2014 /PRNewswire/ -- Two Array BioPharma-invented MEK inhibitors, binimetinib (MEK162) and selumetinib, were showcased at the 50th annual meeting of the American Society of Clinical Oncology (ASCO). At the meeting, preliminary data for the combination of binimetinib and CDK4/6 inhibitor LEE011 (discovered by Novartis Institutes for BioMedical Research in collaboration with Astex...

2014-06-02 12:29:45

Clinical Study Results Published in 2014 ASCO Annual Meeting Proceedings, a Journal of Clinical Oncology CHICAGO, June 2, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), today announced that data from a study published in the 2014 ASCO Annual Meeting Proceedings, a Journal of Clinical Oncology, demonstrates that oncogene mutation load in urinary cell-free DNA, as determined using the company's precision cancer monitoring technology, is significantly correlated with treatment response....

2014-06-02 08:29:32

Phase 1 Study Evaluating Talimogene Laherparepvec Plus Ipilimumab Showed Tolerability at Doses Administered THOUSAND OAKS, Calif., June 2, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from two key clinical trials that support the potential of talimogene laherparepvec, a novel, investigational oncolytic immunotherapy, as both a single agent and as part of a combination regimen in patients with metastatic melanoma. The findings were presented at the 50th...

2014-06-01 08:20:47

The study met the primary endpoint with objective response rates of 41.8% and 32.5% respectively in the 200 mg and 800 mg treatment arms(1,2) EAST HANOVER, N.J., June 1, 2014 /PRNewswire/ -- Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related